The Bolar Exemption in Europe following the EU Pharma Package

May 21, 2026 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Transferable Exclusivity Vouchers for Antimicrobials under the EU Pharma Package

Apr 23, 2026 | Tags: Patents , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Ozempic® Patent Expiry: Have the Scales Finally Tipped?

Apr 17, 2026 | Tags: Patents , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Interpreting Claims After G1/24: Emerging Trends from the Boards of Appeal

Mar 24, 2026 | Tags: Patents

Understanding the EU Pharma Package and how to prepare for its implementation in 2028

Mar 19, 2026 | Tags: Patents , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

Understanding the EU Pharma Incentives Review

Feb 26, 2026 | Tags: Patents , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

UK Supreme Court endorses EPO’s approach to computer-implemented inventions and discards Aerotel

Feb 12, 2026 | Tags: Patents , IP Insight , Aerospace , Automotive , Battery technology , Defence and Security , Engineering , Energy and environment , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences , Renewable energy , Sports , Software , Transportation